Shuang Lin

Shuang Lin practices at Scripps Clinic in San Diego, California.

Shuang Lin's NPI, 1689093684, was assigned on April 8, 2014. Shuang Lin graduated from Indiana University School of Medicine in 2014. Shuang Lin holds California license A138887.

Shuang Lin's primary practice is Scripps Clinic, at 2445 Truxtun Rd Suite 200 Suite 200, San Diego, CA 92106-6154. The practice phone is (858) 554-9100.

Shuang Lin's primary practice is Scripps Clinic in San Diego, California. Shuang Lin is also affiliated with Scripps Mercy Hospital San Diego. The medical group on file is Scripps Clinic Medical Group. Dmand AI also links Shuang Lin to 2 more hospitals, 2 home health agencies and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Shuang Lin practices, 6 sites in all. Vendor and product names are available with a free account.

Family medicine is Shuang Lin's primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Shuang Lin is licensed in California.

CMS data shows 297 Medicare services from Shuang Lin across 9 procedure codes in 2024, for 86 Medicare patients. Medicare paid $22,844 for them. Every service was in an office.

CMS counts 86 Medicare patients who saw Shuang Lin in 2024. The largest group is 65 to 74, with 48 patients. 59% of them have high cholesterol, and 50% have high blood pressure. 15% are also on Medicaid. Their average risk score is 0.92, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Shuang Lin's median patient age at 37, with 76% women.

In 2024, Shuang Lin wrote 138 Medicare Part D claims for 38 patients. 88% of them were for generic drugs. CMS names the drug for 32 of them, across 2 drugs with 11 or more claims each, at $177 in total drug cost. In 2023, CMS named 175 claims across 8 drugs.

Shuang Lin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Shuang Lin as offering telehealth.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Shuang Lin, published from 2020 to 2022. Shuang Lin's most frequent co-author is Jie Jin, MD.

CMS Open Payments shows 22 general payments to Shuang Lin from 12 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 100% of the total. Amgen Inc. paid the most, $326.

Shuang Lin graduated from Indiana University School of Medicine in 2014.